48,466
edits
(→Examples: +CCND1) |
|||
(2 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
|- | |- | ||
| EGFR<ref name=omim131550>{{OMIM|131550}}</ref> | | EGFR<ref name=omim131550>{{OMIM|131550}}</ref> | ||
| [[lung adenocarcinoma]] | | [[lung adenocarcinoma]], [[glioblastoma]],<ref name=Ref_APBR419>{{Ref APBR|419 Q6}}</ref> [[anaplastic astrocytoma]]<ref name=Ref_APBR419>{{Ref APBR|419 Q6}}</ref> | ||
|- | |- | ||
| PDGFB<ref name=omim190040>{{OMIM|190040}}</ref> | | PDGFB<ref name=omim190040>{{OMIM|190040}}</ref> | ||
Line 15: | Line 15: | ||
| [[papillary thyroid carcinoma tall cell variant]] | | [[papillary thyroid carcinoma tall cell variant]] | ||
|- | |- | ||
| KRAS<ref name=omim190070>{{OMIM|190070}}</ref> | | [[KRAS mutation|KRAS]]<ref name=omim190070>{{OMIM|190070}}</ref> | ||
| [[invasive ductal carcinoma of the pancreas]] | | [[invasive ductal carcinoma of the pancreas]] | ||
|- | |- | ||
Line 29: | Line 29: | ||
| CCND1 (BCL1)<ref name=omim168461>{{OMIM|168461}}</ref> | | CCND1 (BCL1)<ref name=omim168461>{{OMIM|168461}}</ref> | ||
| [[mantle cell lymphoma]] | | [[mantle cell lymphoma]] | ||
|- | |||
| EWSR1<ref name=omim133450>{{OMIM|133450}}</ref> | |||
| [[Ewing sarcoma]], [[clear cell sarcoma]], [[DSRCT]], [[extraskeletal myxoid chondrosarcoma|EMC]] | |||
|} | |} | ||
edits